Join our live webinar for an overview of current asthma and COPD treatments, preclinical and early phase developments and much more.
Overview
Embark on a journey from preclinical to clinical studies as our distinguished experts unravel the latest advancements in respiratory health. They will provide profound insights on current treatments for asthma/COPD, late phase investigational medicinal products (IMPs), vaccinations and early stage innovations tailored for this population.
This webinar represents a collective effort to propel knowledge exchange within our community. It offers you a unique opportunity to deepen your understanding, engage in critical discussions and foster collaboration in this rapidly evolving field.
Objective
Attendees will learn about:
- Standard of treatment: explore the latest standard of care for asthma/COPD as Prof. Lapperre unveils crucial advancements, providing invaluable insights into the treatment landscape
- Early stage innovations: stay informed of groundbreaking research in asthma/COPD and vaccinations, and gain a glimpse into the future of drug development
Agenda
- Introduction
- Current standard of care for asthma/COPD treatment
- Innovations in late phase IMPs and vaccinations
- Preclinical and early phase developments in this field
- Q&A session: engage with experts, clarify your concerns
Target Audience: This webinar is aimed at all pharmaceutical and biotech professionals, as well as esteemed pneumologists, house physicians and clinicians.
Language: English
Can't make a live session? Register now and receive a complimentary recording after the live event.
For further information, please contact:
Stacy Dethier
Health Science
Clinical Research Global Marketing Manager
t: +32 15 273 245
